Assembly Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$61,228,000 and profit margin reached -855%. Total operating expenses were $71,809,000.

Profit Margin

Assembly Biosciences, Inc. (NASDAQ:ASMB): Profit margin
2014 0 -23.78M
2015 0 -28.45M
2016 0 -44.26M
2017 9.01M -42.80M -474.66%
2018 14.80M -90.75M -613.02%
2019 15.96M -97.63M -611.63%
2020 79.10M -59.52M -75.25%
2021 6.25M -129.85M -2076.35%
2022 0 -92.07M
2023 7.16M -61.22M -854.78%

ASMB Income Statement (2014 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
7.16M06.25M79.10M15.96M14.80M9.01M000
Cost of revenue
48.9M498K466K101.33K85.32K72.74M44.22M80.25K64.98K0
Gross profit
-41.73M-498K5.78M79.00M15.87M-57.93M-35.20M-80.25K-64.98K0
Operating exp.
Research and development
48.9M69.98M68.52M106.82M85.75M72.74M44.22M33.09M18.35M10.71M
Selling and marketing
0000000000
Total operating expenses
71.80M94.11M97.30M143.88M118.67M107.53M61.24M45.27M29.65M23.95M
Operating income
-64.64M-94.11M-132.68M-64.77M-102.71M-92.73M-52.22M-45.27M-29.65M-23.95M
Other income (expenses), net
3.45M1.02M302K2.62M4.30M3.08M368.20K-1.13M1.20M167.65K
Income before tax
-61.19M-93.09M-132.38M-62.15M-98.40M-89.65M-51.85M-44.87M-28.45M-23.78M
Income tax expense
33K-1.02M-2.53M-2.62M-774K1.09M-9.05M-617.67K-1.20M0
Net income
-61.22M-92.07M-129.85M-59.52M-97.63M-90.75M-42.80M-44.26M-28.45M-23.78M
Earnings per share
Basic EPS
-13.38-22.82-36-1.5-44.62-3.98-2.41-2.57-1.81-3.4
Diluted EPS
-13.38-22.82-36-1.5-44.62-3.98-2.41-2.57-1.81-3.4
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source